IMS's Incivek reporting hitch spurs stock swing
Marc Iskowitz
November 01 2011
IMS Health continues to assess a data-supply glitch that led to an underreporting of prescriptions for Vertex Pharmaceuticals' hepatitis C ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.